Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Clinical Presentation, Diagnosis, and Radiological Findings of Neoplastic Meningitis.

Rigakos G, Liakou CI, Felipe N, Orkoulas-Razis D, Razis E.

Cancer Control. 2017 Jan;24(1):9-21. Review.


A Tongue Lesion as a Sign of a Systemic Disease.

Liakou CI, Koh J, Tsimpidakis A, Rios K, Paskalis C, Pipilis A, Kantianis D, Georgiadis T, Razis E.

Case Rep Med. 2016;2016:6723575. doi: 10.1155/2016/6723575. Epub 2016 Mar 22.


CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.

Gogali F, Paterakis G, Rassidakis GZ, Liakou CI, Liapi C.

Thyroid. 2013 Dec;23(12):1561-8. doi: 10.1089/thy.2012.0560. Epub 2013 Nov 6.


Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.

Gogali F, Paterakis G, Rassidakis GZ, Kaltsas G, Liakou CI, Gousis P, Neonakis E, Manoussakis MN, Liapi C.

J Clin Endocrinol Metab. 2012 May;97(5):1474-82. doi: 10.1210/jc.2011-1838. Epub 2012 Mar 7.


Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.

Chen H, Liakou CI, Kamat A, Pettaway C, Ward JF, Tang DN, Sun J, Jungbluth AA, Troncoso P, Logothetis C, Sharma P.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2729-34. doi: 10.1073/pnas.0813175106. Epub 2009 Feb 6.


CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients.

Liakou CI, Kamat A, Tang DN, Chen H, Sun J, Troncoso P, Logothetis C, Sharma P.

Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14987-92. doi: 10.1073/pnas.0806075105. Epub 2008 Sep 25.


Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

Liakou CI, Narayanan S, Ng Tang D, Logothetis CJ, Sharma P.

Cancer Immun. 2007 Jun 26;7:10. Review.


Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.

Konoplev S, Rassidakis GZ, Estey E, Kantarjian H, Liakou CI, Huang X, Xiao L, Andreeff M, Konopleva M, Medeiros LJ.

Cancer. 2007 Mar 15;109(6):1152-6.

Supplemental Content

Loading ...
Support Center